Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 248

1.

Diabetic calcaneal osteomyelitis.

Waibel FWA, Uçkay I, Sairanen K, Waibel L, Berli MC, Böni T, Gariani K, Lipsky BA.

Infez Med. 2019 Sep 1;27(3):225-238.

2.

Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT.

Scarborough M, Li HK, Rombach I, Zambellas R, Walker AS, McNally M, Atkins B, Kümin M, Lipsky BA, Hughes H, Bose D, Warren S, Mack D, Folb J, Moore E, Jenkins N, Hopkins S, Seaton RA, Hemsley C, Sandoe J, Aggarwal I, Ellis S, Sutherland R, Geue C, McMeekin N, Scarborough C, Paul J, Cooke G, Bostock J, Khatamzas E, Wong N, Brent A, Lomas J, Matthews P, Wangrangsimakul T, Gundle R, Rogers M, Taylor A, Thwaites GE, Bejon P.

Health Technol Assess. 2019 Aug;23(38):1-92. doi: 10.3310/hta23380.

3.

Utility of Culturing Marginal Bone in Patients Undergoing Lower Limb Amputation for Infection.

Shiraev TP, Lipsky BA, Kwok TMY, Robinson DA.

J Foot Ankle Surg. 2019 Sep;58(5):847-851. doi: 10.1053/j.jfas.2018.12.012. Epub 2019 Jul 23.

PMID:
31345756
4.

Four versus six weeks of antibiotic therapy for osteoarticular infections after implant removal: a randomized trial.

Benkabouche M, Racloz G, Spechbach H, Lipsky BA, Gaspoz JM, Uçkay I.

J Antimicrob Chemother. 2019 Aug 1;74(8):2394-2399. doi: 10.1093/jac/dkz202.

PMID:
31106353
5.

Two weeks versus four weeks of antibiotic therapy after surgical drainage for native joint bacterial arthritis: a prospective, randomised, non-inferiority trial.

Gjika E, Beaulieu JY, Vakalopoulos K, Gauthier M, Bouvet C, Gonzalez A, Morello V, Steiger C, Hirsiger S, Lipsky BA, Uçkay I.

Ann Rheum Dis. 2019 Aug;78(8):1114-1121. doi: 10.1136/annrheumdis-2019-215116. Epub 2019 Apr 16.

6.

Diagnosis and Management of Diabetic Foot Complications.

Boulton AJM, Armstrong DG, Kirsner RS, Attinger CE, Lavery LA, Lipsky BA, Mills JL Sr., Steinberg JS.

Arlington (VA): American Diabetes Association; 2018 Oct.

7.

Symptoms Associated With Pertussis Are Insufficient to Rule In or Rule Out the Diagnosis.

Cornia PB, Lipsky BA.

Chest. 2019 Feb;155(2):449-450. doi: 10.1016/j.chest.2018.10.028. No abstract available.

PMID:
30732694
8.

Oral amoxicillin-clavulanate for treating diabetic foot infections.

Gariani K, Lebowitz D, Kressmann B, von Dach E, Sendi P, Waibel F, Berli M, Huber T, Lipsky BA, Uçkay I.

Diabetes Obes Metab. 2019 Jun;21(6):1483-1486. doi: 10.1111/dom.13651. Epub 2019 Mar 12.

PMID:
30719838
9.

Oral versus Intravenous Antibiotics for Bone and Joint Infection.

Li HK, Rombach I, Zambellas R, Walker AS, McNally MA, Atkins BL, Lipsky BA, Hughes HC, Bose D, Kümin M, Scarborough C, Matthews PC, Brent AJ, Lomas J, Gundle R, Rogers M, Taylor A, Angus B, Byren I, Berendt AR, Warren S, Fitzgerald FE, Mack DJF, Hopkins S, Folb J, Reynolds HE, Moore E, Marshall J, Jenkins N, Moran CE, Woodhouse AF, Stafford S, Seaton RA, Vallance C, Hemsley CJ, Bisnauthsing K, Sandoe JAT, Aggarwal I, Ellis SC, Bunn DJ, Sutherland RK, Barlow G, Cooper C, Geue C, McMeekin N, Briggs AH, Sendi P, Khatamzas E, Wangrangsimakul T, Wong THN, Barrett LK, Alvand A, Old CF, Bostock J, Paul J, Cooke G, Thwaites GE, Bejon P, Scarborough M; OVIVA Trial Collaborators.

N Engl J Med. 2019 Jan 31;380(5):425-436. doi: 10.1056/NEJMoa1710926.

10.

Principles and practice of antibiotic stewardship in the management of diabetic foot infections.

Uçkay I, Berli M, Sendi P, Lipsky BA.

Curr Opin Infect Dis. 2019 Apr;32(2):95-101. doi: 10.1097/QCO.0000000000000530.

PMID:
30664029
11.

Remission in diabetic foot infections: Duration of antibiotic therapy and other possible associated factors.

Gariani K, Lebowitz D, von Dach E, Kressmann B, Lipsky BA, Uçkay I.

Diabetes Obes Metab. 2019 Feb;21(2):244-251. doi: 10.1111/dom.13507. Epub 2018 Sep 21.

PMID:
30129109
12.
13.

Understanding the microbiome of diabetic foot osteomyelitis: insights from molecular and microscopic approaches.

Johani K, Fritz BG, Bjarnsholt T, Lipsky BA, Jensen SO, Yang M, Dean A, Hu H, Vickery K, Malone M.

Clin Microbiol Infect. 2019 Mar;25(3):332-339. doi: 10.1016/j.cmi.2018.04.036. Epub 2018 May 19.

PMID:
29787888
14.

A randomized controlled trial of the safety and efficacy of a topical gentamicin-collagen sponge in diabetic patients with a mild foot ulcer infection.

Uçkay I, Kressmann B, Di Tommaso S, Portela M, Alwan H, Vuagnat H, Maître S, Paoli C, Lipsky BA.

SAGE Open Med. 2018 May 13;6:2050312118773950. doi: 10.1177/2050312118773950. eCollection 2018.

15.

Native septic arthritis is not an immediate surgical emergency.

Lauper N, Davat M, Gjika E, Müller C, Belaieff W, Pittet D, Lipsky BA, Hannouche D, Uçkay I.

J Infect. 2018 Jul;77(1):47-53. doi: 10.1016/j.jinf.2018.02.015. Epub 2018 May 6.

PMID:
29742468
16.

Virulence Factor Genes in Staphylococcus aureus Isolated From Diabetic Foot Soft Tissue and Bone Infections.

Víquez-Molina G, Aragón-Sánchez J, Pérez-Corrales C, Murillo-Vargas C, López-Valverde ME, Lipsky BA.

Int J Low Extrem Wounds. 2018 Mar;17(1):36-41. doi: 10.1177/1534734618764237. Epub 2018 Mar 22.

PMID:
29564946
17.

An Overview on Diabetic Foot Infections, including Issues Related to Associated Pain, Hyperglycemia and Limb Ischemia.

Uckay I, Jornayvaz FR, Lebowitz D, Gastaldi G, Gariani K, Lipsky BA.

Curr Pharm Des. 2018;24(12):1243-1254. doi: 10.2174/1381612824666180302145754. Review.

PMID:
29508677
18.

CODIFI (Concordance in Diabetic Foot Ulcer Infection): a cross-sectional study of wound swab versus tissue sampling in infected diabetic foot ulcers in England.

Nelson A, Wright-Hughes A, Backhouse MR, Lipsky BA, Nixon J, Bhogal MS, Reynolds C, Brown S; CODIFI collaborators.

BMJ Open. 2018 Jan 31;8(1):e019437. doi: 10.1136/bmjopen-2017-019437.

19.

Risk Factors for Infection with Pseudomonas aeruginosa in Diabetic Foot Infections.

Ertugrul BM, Lipsky BA, Ture M, Sakarya S.

J Am Podiatr Med Assoc. 2017 Nov;107(6):483-489. doi: 10.7547/15-167.

PMID:
29252023
20.

Modern management of diabetic foot osteomyelitis. The when, how and why of conservative approaches.

Aragón-Sánchez J, Lipsky BA.

Expert Rev Anti Infect Ther. 2018 Jan;16(1):35-50. doi: 10.1080/14787210.2018.1417037. Epub 2017 Dec 19. Review.

PMID:
29231774
21.

Prognosis of the infected diabetic foot ulcer: a 12-month prospective observational study.

Ndosi M, Wright-Hughes A, Brown S, Backhouse M, Lipsky BA, Bhogal M, Reynolds C, Vowden P, Jude EB, Nixon J, Nelson EA.

Diabet Med. 2018 Jan;35(1):78-88. doi: 10.1111/dme.13537. Epub 2017 Nov 20.

22.

Virulence genes fliC, toxA and phzS are common among Pseudomonas aeruginosa isolates from diabetic foot infections.

Ertugrul BM, Oryasin E, Lipsky BA, Willke A, Bozdogan B.

Infect Dis (Lond). 2018 Apr;50(4):273-279. doi: 10.1080/23744235.2017.1393839. Epub 2017 Oct 27.

PMID:
29078729
23.

Antibiotic therapy duration for prosthetic joint infections treated by Debridement and Implant Retention (DAIR): Similar long-term remission for 6 weeks as compared to 12 weeks.

Chaussade H, Uçkay I, Vuagnat A, Druon J, Gras G, Rosset P, Lipsky BA, Bernard L.

Int J Infect Dis. 2017 Oct;63:37-42. doi: 10.1016/j.ijid.2017.08.002. Epub 2017 Aug 10.

24.

Detection of Osteomyelitis in the Diabetic Foot by Imaging Techniques: A Systematic Review and Meta-analysis Comparing MRI, White Blood Cell Scintigraphy, and FDG-PET.

Lauri C, Tamminga M, Glaudemans AWJM, Juárez Orozco LE, Erba PA, Jutte PC, Lipsky BA, IJzerman MJ, Signore A, Slart RHJA.

Diabetes Care. 2017 Aug;40(8):1111-1120. doi: 10.2337/dc17-0532. Review.

PMID:
28733376
25.

Topical antimicrobial agents for treating foot ulcers in people with diabetes.

Dumville JC, Lipsky BA, Hoey C, Cruciani M, Fiscon M, Xia J.

Cochrane Database Syst Rev. 2017 Jun 14;6:CD011038. doi: 10.1002/14651858.CD011038.pub2. Review.

26.

One- vs 2-Stage Bursectomy for Septic Olecranon and Prepatellar Bursitis: A Prospective Randomized Trial.

Uçkay I, von Dach E, Perez C, Agostinho A, Garnerin P, Lipsky BA, Hoffmeyer P, Pittet D.

Mayo Clin Proc. 2017 Jul;92(7):1061-1069. doi: 10.1016/j.mayocp.2017.03.011. Epub 2017 Jun 8.

PMID:
28602435
27.

Staphylococcus aureus soft tissue infection may increase the risk of subsequent staphylococcal soft tissue infections.

Bouvet C, Gjoni S, Zenelaj B, Lipsky BA, Hakko E, Uçkay I.

Int J Infect Dis. 2017 Jul;60:44-48. doi: 10.1016/j.ijid.2017.05.002. Epub 2017 May 6.

28.

A Proposed New Classification of Skin and Soft Tissue Infections Modeled on the Subset of Diabetic Foot Infection.

Lipsky BA, Silverman MH, Joseph WS.

Open Forum Infect Dis. 2016 Dec 7;4(1):ofw255. doi: 10.1093/ofid/ofw255. eCollection 2017 Winter. Review.

29.

Are antibiotic-resistant pathogens more common in subsequent episodes of diabetic foot infection?

Lebowitz D, Gariani K, Kressmann B, Dach EV, Huttner B, Bartolone P, Lê N, Mohamad M, Lipsky BA, Uçkay I.

Int J Infect Dis. 2017 Jun;59:61-64. doi: 10.1016/j.ijid.2017.04.012. Epub 2017 Apr 24.

30.

An Assessment of Intralesional Epidermal Growth Factor for Treating Diabetic Foot WoundsThe First Experiences in Turkey.

Ertugrul BM, Lipsky BA, Guvenc U; Turkish Intralesional Epidermal Growth Factor Study Group for Diabetic Foot Wounds.

J Am Podiatr Med Assoc. 2017 Jan;107(1):17-29. doi: 10.7547/15-056.

PMID:
28271944
31.

Prevention and management of foot problems in diabetes: A Summary Guidance for Daily Practice 2015, based on the IWGDF guidance documents.

Schaper NC, Van Netten JJ, Apelqvist J, Lipsky BA, Bakker K; International Working Group on the Diabetic Foot (IWGDF).

Diabetes Res Clin Pract. 2017 Feb;124:84-92. doi: 10.1016/j.diabres.2016.12.007. Epub 2016 Dec 18. Review.

PMID:
28119194
32.

Non-surgical treatment of diabetic foot osteomyelitis.

Mutluoglu M, Lipsky BA.

Lancet Diabetes Endocrinol. 2017 Aug;5(8):668. doi: 10.1016/S2213-8587(16)30141-3. Epub 2017 Jan 18. No abstract available.

PMID:
28108304
33.

Chronic Cough.

Cornia PB, Lipsky BA.

N Engl J Med. 2017 Jan 12;376(2):183. No abstract available.

PMID:
28079336
34.

Concordance in diabetic foot ulceration: a cross-sectional study of agreement between wound swabbing and tissue sampling in infected ulcers.

Nelson EA, Wright-Hughes A, Brown S, Lipsky BA, Backhouse M, Bhogal M, Ndosi M, Reynolds C, Sykes G, Dowson C, Edmonds M, Vowden P, Jude EB, Dickie T, Nixon J.

Health Technol Assess. 2016 Nov;20(82):1-176.

35.

Diabetic foot osteomyelitis.

Mutluoglu M, Lipsky BA.

CMAJ. 2016 Dec 6;188(17-18):E535. doi: 10.1503/cmaj.160228. Epub 2016 Oct 17. No abstract available.

37.

Antimicrobial stewardship in wound care: a Position Paper from the British Society for Antimicrobial Chemotherapy and European Wound Management Association.

Lipsky BA, Dryden M, Gottrup F, Nathwani D, Seaton RA, Stryja J.

J Antimicrob Chemother. 2016 Nov;71(11):3026-3035. Epub 2016 Jul 25. Review.

PMID:
27494918
38.

Consensus on surgical aspects of managing osteomyelitis in the diabetic foot.

Allahabadi S, Haroun KB, Musher DM, Lipsky BA, Barshes NR.

Diabet Foot Ankle. 2016 Jul 12;7:30079. doi: 10.3402/dfa.v7.30079. eCollection 2016.

39.

[Microbiology and antibiotic treatment of diabetic foot infection].

Zanella MC, Kressmann B, Wuarin L, Coulin B, Maître S, Suva D, Lipsky BA, Uçkay I.

Rev Med Suisse. 2016 Apr 13;12(514):732-7. French.

PMID:
27263148
40.

Closed incision negative pressure therapy: international multidisciplinary consensus recommendations.

Willy C, Agarwal A, Andersen CA, Santis G, Gabriel A, Grauhan O, Guerra OM, Lipsky BA, Malas MB, Mathiesen LL, Singh DP, Reddy VS.

Int Wound J. 2017 Apr;14(2):385-398. doi: 10.1111/iwj.12612. Epub 2016 May 12. Review.

PMID:
27170231
41.

Negative Pressure Wound Therapy With Instillation: Review of Evidence and Recommendations.

Kim PJ, Attinger CE, Crist BD, Gabriel A, Galiano RD, Gupta S, Lantis Ii JC, Lavery L, Lipsky BA, Teot L.

Wounds. 2015 Dec;27(12):S2-S19.

42.

Causative pathogens and antibiotic resistance in diabetic foot infections: A prospective multi-center study.

Hatipoglu M, Mutluoglu M, Turhan V, Uzun G, Lipsky BA; Turk-Day Study Group, Sevim E, Demiraslan H, Eryilmaz E, Ozuguz C, Memis A, Ay H, Arda B, Uysal S, Motor VK, Kader C, Erturk A, Coskun O, Duygu F, Guler S, Altay FA, Ogutlu A, Bolukcu S, Yildiz S, Kandemir O, Aslaner H, Polat A, Karahocagil MK, Yasar KK, Sehmen E, Kilic S, Sunbul M, Gencer S, Bozkurt F, Yanik T, Oztoprak N, Batirel A, Sozen H, Kilic I, Celik I, Ay B, Tosun S, Kadanali A, Çomoglu S, Denk A, Hosoglu S, Aydin O, Elaldi N, Akalin S, Kandemir B, Akbulut A, Demirdal T, Balik R, Azak E, Sengoz G.

J Diabetes Complications. 2016 Jul;30(5):910-6. doi: 10.1016/j.jdiacomp.2016.02.013. Epub 2016 Feb 21.

PMID:
26965794
43.

Diabetic foot infections: recent literature and cornerstones of management.

Uçkay I, Gariani K, Dubois-Ferrière V, Suvà D, Lipsky BA.

Curr Opin Infect Dis. 2016 Apr;29(2):145-52. doi: 10.1097/QCO.0000000000000243. Review.

PMID:
26779774
44.

Oral versus intravenous antibiotic treatment for bone and joint infections (OVIVA): study protocol for a randomised controlled trial.

Li HK, Scarborough M, Zambellas R, Cooper C, Rombach I, Walker AS, Lipsky BA, Briggs A, Seaton A, Atkins B, Woodhouse A, Berendt A, Byren I, Angus B, Pandit H, Stubbs D, McNally M, Thwaites G, Bejon P.

Trials. 2015 Dec 21;16:583. doi: 10.1186/s13063-015-1098-y.

45.

Factors Associated With Treatment Failure of Infected Pressure Sores.

Jugun K, Richard JC, Lipsky BA, Kressmann B, Pittet-Cuenod B, Suvà D, Modarressi A, Uçkay I.

Ann Surg. 2016 Aug;264(2):399-403. doi: 10.1097/SLA.0000000000001497.

PMID:
26501707
46.

Diabetic foot infections: what have we learned in the last 30 years?

Uçkay I, Aragón-Sánchez J, Lew D, Lipsky BA.

Int J Infect Dis. 2015 Nov;40:81-91. doi: 10.1016/j.ijid.2015.09.023. Epub 2015 Oct 13. Review.

47.

Stopping Antibiotic Therapy for a Diabetic Foot Infection: Some Answers, but More Questions.

Lipsky BA.

Int J Low Extrem Wounds. 2015 Sep;14(3):307-8. doi: 10.1177/1534734615607145. No abstract available.

PMID:
26453672
48.

Diabetic foot infections: Current treatment and delaying the 'post-antibiotic era'.

Lipsky BA.

Diabetes Metab Res Rev. 2016 Jan;32 Suppl 1:246-53. doi: 10.1002/dmrr.2739. Review.

PMID:
26452233
49.

The 2015 IWGDF guidance documents on prevention and management of foot problems in diabetes: development of an evidence-based global consensus.

Bakker K, Apelqvist J, Lipsky BA, Van Netten JJ; International Working Group on the Diabetic Foot.

Diabetes Metab Res Rev. 2016 Jan;32 Suppl 1:2-6. doi: 10.1002/dmrr.2694.

PMID:
26409930
50.

IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes.

Lipsky BA, Aragón-Sánchez J, Diggle M, Embil J, Kono S, Lavery L, Senneville É, Urbančič-Rovan V, Van Asten S; International Working Group on the Diabetic Foot, Peters EJ.

Diabetes Metab Res Rev. 2016 Jan;32 Suppl 1:45-74. doi: 10.1002/dmrr.2699. No abstract available.

PMID:
26386266

Supplemental Content

Loading ...
Support Center